Christian Waeber

Cork, M, Ireland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 39 publications

Behavioral assessment of neuropsychiatric outcomes in rodent stroke models.

Behavioral assessment of neuropsychiatric outcomes in rodent stroke models.

Journal: Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism

Published: March 20, 2025

Discovery of Sphingosine Kinase Inhibition by Modified Quinoline-5,8-Diones.

Discovery of Sphingosine Kinase Inhibition by Modified Quinoline-5,8-Diones.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: January 13, 2025

Extended siponimod release via low-porosity PLGA fibres: a comprehensive three-month in vitro evaluation for neovascular ocular diseases.

Extended siponimod release via low-porosity PLGA fibres: a comprehensive three-month in vitro evaluation for neovascular ocular diseases.

Journal: Biomaterials science

Published: August 19, 2024

In Vivo Ocular Pharmacokinetics and Toxicity of Siponimod in Albino Rabbits.

In Vivo Ocular Pharmacokinetics and Toxicity of Siponimod in Albino Rabbits.

Journal: Molecular pharmaceutics

Published: June 10, 2024

The 5-HT1F receptor as the target of ditans in migraine - from bench to bedside.

The 5-HT1F receptor as the target of ditans in migraine - from bench to bedside.

Journal: Nature reviews. Neurology

Published: June 12, 2023

The impact of fingolimod on Treg function in brain ischaemia.

The impact of fingolimod on Treg function in brain ischaemia.

Journal: European journal of immunology

Published: January 03, 2023

Siponimod As a Novel Inhibitor of Retinal Angiogenesis: In Vitro and In Vivo Evidence of Therapeutic Efficacy.

Siponimod As a Novel Inhibitor of Retinal Angiogenesis: In Vitro and In Vivo Evidence of Therapeutic Efficacy.

Journal: The Journal of pharmacology and experimental therapeutics

Published: November 29, 2022

Fingolimod Does Not Reduce Infarction After Focal Cerebral Ischemia in Mice During Active or Inactive Circadian Phases.

Fingolimod Does Not Reduce Infarction After Focal Cerebral Ischemia in Mice During Active or Inactive Circadian Phases.

Journal: Stroke

Published: October 17, 2022

Estrogen modulation of cortical spreading depression.

Estrogen modulation of cortical spreading depression.

Journal: The journal of headache and pain

Published: June 15, 2022

Recombinant pregnancy-specific glycoprotein-1-Fc reduces functional deficit in a mouse model of permanent brain ischaemia.

Recombinant pregnancy-specific glycoprotein-1-Fc reduces functional deficit in a mouse model of permanent brain ischaemia.

Journal: Brain, behavior, & immunity - health

Published: June 14, 2022

Preclinical Evaluation of Fingolimod in Rodent Models of Stroke With Age or Atherosclerosis as Comorbidities.

Preclinical Evaluation of Fingolimod in Rodent Models of Stroke With Age or Atherosclerosis as Comorbidities.

Journal: Frontiers in pharmacology

Published: April 14, 2022

Polymer based sustained drug delivery to the ocular posterior segment: barriers and future opportunities for the treatment of neovascular pathologies.

Polymer based sustained drug delivery to the ocular posterior segment: barriers and future opportunities for the treatment of neovascular pathologies.

Journal: Advanced drug delivery reviews

Published: February 04, 2022

Showing 1-12 of 39

Last Updated: 09/26/2026